NLRP3 and hepatocellular carcinoma: In the present study, NLRP3 and CASP1 expression levels are lower in poorly differentiated HCC (grade III) when compared with mild/moderately differentiated HCC (grade I-II) which are statistically significant for NLRP3, but not for CASP1.